Meet CRI’s New CEO Alicia Zhou, PhD

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Cancer Research Institute Event Calendar

2018 Immuno-Oncology 360°

The fourth annual Immuno-Oncology 360° meeting will be held on February 7-9, 2018 at the Roosevelt Hotel, New York City. Led by Dr Axel Hoos and Dr James Gulley, IO360° addresses the most current data to help foster collaboration across all IO stakeholders—scientific, clinical, and business—and transform the way cancer is treated.

The Cancer Research Institute is an educational partner of the conference. As part of our participation at IO360°, we are pleased to offer friends and colleagues a special 20% discount. If you would like to take advantage of this option, please register for the conference with code CRI20.

Featured Speakers

Andrew Baum, MD, Citi (Keynote)
Axel Hoos, MD, PhD, GlaxoSmithKline (Lead Advisor)
James Gulley, MD, PhD, National Cancer Institute (Lead Advisor)

Plenary Sessions

Discovery and Preclinical
Investor Relations in Immunotherapy
Translational Science and Biomarkers
New Trends and Collaborations
IO Emerging Technologies
Clinical Operations in IO
Business Aspects
Clinical Development
Trout Situation Room

Projected Attendance

400+ executives
45+ speakers
30+ talks
25+ exhibitors
10+ hours for networking
1×1 Partnering Tool

Follow the event hashtag #IO360nyc for updates.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.